Skip to main content
LUMO logo

Lumos Pharma, Inc. (LUMO) Stock Analysis

DELISTED 2024

What happened to Lumos Pharma, Inc. (LUMO) stock?

Lumos Pharma, Inc. (LUMO) no longer trades on public markets. It was delisted in December 2024. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
Delisting date:
December 2024
Last recorded price (historical):
$4.34 (last quote on record before the December 2024 delisting; historical, not a current quote)
MCap: $37.5M| Vol: 390.9K| 52-wk range: $1.37 – $4.58

Market cap $37.5M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Lumos Pharma, Inc. (LUMO). Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for rare diseases. Their lead candidate, LUM-201, is in Phase 2 clinical trials for pediatric growth hormone deficiency and other endocrine disorders.

Last analyzed: Mar 18, 2026
Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for rare diseases. Their lead candidate, LUM-201, is in Phase 2 clinical trials for pediatric growth hormone deficiency and other endocrine disorders.

Dated analysis: the newest financial statements on file are 25 months old (Sep 1, 2024), so the figures and score below describe that period, not today.

Lumos Pharma, Inc. (LUMO) Healthcare & Pipeline Overview

Employees30
Model self-rating on this text: 81% (not a measure of the evidence) Updated: Mar 18, 2026

More about this archive record

Can I still buy LUMO shares?

No. LUMO stopped trading on public markets in December 2024, so the shares are not available through a broker. Anything you see quoted for LUMO elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before LUMO stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Lumos Pharma, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.